Steve A Webb
Overview
Explore the profile of Steve A Webb including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
1778
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Mahar R, McGlothlin A, Dymock M, Barina L, Bonten M, Bowen A, et al.
Trials
. 2025 Feb;
26(1):49.
PMID: 39934879
Platform trials have become widely adopted across multiple disease areas over recent years, however, guidelines for operationalising these trials have not kept pace. We outline a series of documents that...
3.
Glasbey J, Webb S, Peel T, Pinkney T, Myles P
Br J Anaesth
. 2024 Dec;
134(2):259-262.
PMID: 39706702
Large, randomised trials are the bedrock of evidence-based medicine, but the resources required to complete such trials greatly limit the number of important clinical questions that can be addressed within...
4.
Glasbey J, Webb S, Peel T, Pinkney T, Myles P
Br J Surg
. 2024 Dec;
111(12).
PMID: 39701591
Large, randomized trials are the bedrock of evidence-based medicine, but the resources required to complete such trials greatly limit the number of important clinical questions that can be addressed within...
5.
Axfors C, Schmitt A, Janiaud P, Vant Hooft J, Abd-Elsalam S, Abdo E, et al.
Nat Commun
. 2024 Feb;
15(1):1075.
PMID: 38316844
No abstract available.
6.
Higgins A, Peake S, Rinaldo Bellomo A, Ao D, Delaney A, Howe B, et al.
Crit Care Resusc
. 2023 Dec;
23(3):329-336.
PMID: 38046082
To determine the cost-effectiveness of early goal-directed therapy (EGDT) for patients with early septic shock. Within-trial cost-effectiveness evaluation. Nineteen hospitals in Australia and New Zealand. Patients with early septic shock...
7.
Burrell A, Serpa Neto A, Broadley T, Trapani T, Begum H, Campbell L, et al.
Crit Care Resusc
. 2023 Dec;
23(3):308-319.
PMID: 38046076
To report longitudinal differences in baseline characteristics, treatment, and outcomes in patients with coronavirus disease 2019 (COVID-19) admitted to intensive care units (ICUs) between the first and second waves of...
8.
de Kretser D, Mora J, Bloomfield M, Campbell A, Cheng M, Guy S, et al.
Clin Infect Dis
. 2023 Nov;
79(4):871-887.
PMID: 37921609
Background: Staphylococcus aureus bloodstream infection (bacteremia) is traditionally treated with at least 2 weeks of intravenous (IV) antibiotics in adults, 3-7 days in children, and often longer for those with...
9.
Hills T, Lorenzi E, Berry L, Shyamsundar M, Al-Beidh F, Annane D, et al.
N Engl J Med
. 2023 Oct;
389(25):2341-2354.
PMID: 37888913
Background: The efficacy of simvastatin in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear. Methods: In an ongoing international, multifactorial, adaptive platform, randomized, controlled trial, we evaluated simvastatin...
10.
Adhikari N, Hashmi M, Vijayaraghavan B, Haniffa R, Beane A, Webb S, et al.
JAMA
. 2023 Oct;
330(18):1745-1759.
PMID: 37877585
Importance: The efficacy of vitamin C for hospitalized patients with COVID-19 is uncertain. Objective: To determine whether vitamin C improves outcomes for patients with COVID-19. Design, Setting, And Participants: Two...